Varicella zoster virus DNA vaccine

Drug Profile

Varicella zoster virus DNA vaccine

Latest Information Update: 30 Apr 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Gene therapies; Varicella vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Varicella zoster virus infections

Most Recent Events

  • 16 Mar 2000 A preclinical study has been added to the Viral Infections immunogenicity section
  • 13 Mar 1998 New profile
  • 13 Mar 1998 Preclinical development for Varicella zoster virus infections in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top